206 related articles for article (PubMed ID: 15134625)
1. Endocrine outcome in children with medulloblastoma treated with 18 Gy of craniospinal radiation therapy.
Xu W; Janss A; Packer RJ; Phillips P; Goldwein J; Moshang T
Neuro Oncol; 2004 Apr; 6(2):113-8. PubMed ID: 15134625
[TBL] [Abstract][Full Text] [Related]
2. Adult height and adult sitting height in childhood medulloblastoma survivors.
Xu W; Janss A; Moshang T
J Clin Endocrinol Metab; 2003 Oct; 88(10):4677-81. PubMed ID: 14557440
[TBL] [Abstract][Full Text] [Related]
3. Adult height after growth hormone (GH) treatment for GH deficiency due to cranial irradiation.
Adan L; Sainte-Rose C; Souberbielle JC; Zucker JM; Kalifa C; Brauner R
Med Pediatr Oncol; 2000 Jan; 34(1):14-9. PubMed ID: 10611579
[TBL] [Abstract][Full Text] [Related]
4. Proton radiation therapy for pediatric medulloblastoma and supratentorial primitive neuroectodermal tumors: outcomes for very young children treated with upfront chemotherapy.
Jimenez RB; Sethi R; Depauw N; Pulsifer MB; Adams J; McBride SM; Ebb D; Fullerton BC; Tarbell NJ; Yock TI; Macdonald SM
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):120-6. PubMed ID: 23790826
[TBL] [Abstract][Full Text] [Related]
5. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study.
Packer RJ; Goldwein J; Nicholson HS; Vezina LG; Allen JC; Ris MD; Muraszko K; Rorke LB; Wara WM; Cohen BH; Boyett JM
J Clin Oncol; 1999 Jul; 17(7):2127-36. PubMed ID: 10561268
[TBL] [Abstract][Full Text] [Related]
6. Ovarian function in survivors of childhood medulloblastoma: Impact of reduced dose craniospinal irradiation and high-dose chemotherapy with autologous stem cell rescue.
Balachandar S; Dunkel IJ; Khakoo Y; Wolden S; Allen J; Sklar CA
Pediatr Blood Cancer; 2015 Feb; 62(2):317-321. PubMed ID: 25346052
[TBL] [Abstract][Full Text] [Related]
7. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.
Merchant TE; Kun LE; Krasin MJ; Wallace D; Chintagumpala MM; Woo SY; Ashley DM; Sexton M; Kellie SJ; Ahern V; Gajjar A
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):782-7. PubMed ID: 17892918
[TBL] [Abstract][Full Text] [Related]
8. A pilot study of preirradiation chemotherapy and 1800 cGy craniospinal irradiation in young children with medulloblastoma.
Jakacki RI; Feldman H; Jamison C; Boaz JC; Luerssen TG; Timmerman R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):531-6. PubMed ID: 15380589
[TBL] [Abstract][Full Text] [Related]
9. Longterm treatment results of childhood medulloblastoma by craniospinal irradiation in supine position.
Slampa P; Pavelka Z; Dusek L; Hynkova L; Sterba J; Ondrova B; Princ D; Novotny T; Kostakova S
Neoplasma; 2007; 54(1):62-7. PubMed ID: 17203894
[TBL] [Abstract][Full Text] [Related]
10. Long-term neuro-endocrine sequelae after treatment for childhood medulloblastoma.
Heikens J; Michiels EM; Behrendt H; Endert E; Bakker PJ; Fliers E
Eur J Cancer; 1998 Sep; 34(10):1592-7. PubMed ID: 9893634
[TBL] [Abstract][Full Text] [Related]
11. Outcome of medulloblastoma in children treated with reduced-dose radiation therapy plus adjuvant chemotherapy.
Sirachainan N; Nuchprayoon I; Thanarattanakorn P; Pakakasama S; Lusawat A; Visudibhan A; Dhanachai M; Larbcharoensub N; Amornfa J; Shotelersuk K; Katanyuwong K; Tangkaratt S; Hongeng S
J Clin Neurosci; 2011 Apr; 18(4):515-9. PubMed ID: 21310618
[TBL] [Abstract][Full Text] [Related]
12. Effects of puberty on bone age maturation in a girl after medulloblastoma therapy.
Marx M; Schoof E; Grabenbauer GG; Beck JD; Doerr HG
J Pediatr Adolesc Gynecol; 1999 May; 12(2):62-6. PubMed ID: 10326189
[TBL] [Abstract][Full Text] [Related]
13. Endocrine outcomes with proton and photon radiotherapy for standard risk medulloblastoma.
Eaton BR; Esiashvili N; Kim S; Patterson B; Weyman EA; Thornton LT; Mazewski C; MacDonald TJ; Ebb D; MacDonald SM; Tarbell NJ; Yock TI
Neuro Oncol; 2016 Jun; 18(6):881-7. PubMed ID: 26688075
[TBL] [Abstract][Full Text] [Related]
14. [Growth hormone deficiency after treatment of medulloblastoma with radiotherapy in childhood: case report].
Goldberg TB; Rodrigues MA; Takata RT; Nogueira CR; Faleiros AT
Arq Neuropsiquiatr; 2003 Jun; 61(2B):482-5. PubMed ID: 12894290
[TBL] [Abstract][Full Text] [Related]
15. Cumulative incidence of radiation-induced cavernomas in long-term survivors of medulloblastoma.
Lew SM; Morgan JN; Psaty E; Lefton DR; Allen JC; Abbott R
J Neurosurg; 2006 Feb; 104(2 Suppl):103-7. PubMed ID: 16506497
[TBL] [Abstract][Full Text] [Related]
16. Critical combinations of radiation dose and volume predict intelligence quotient and academic achievement scores after craniospinal irradiation in children with medulloblastoma.
Merchant TE; Schreiber JE; Wu S; Lukose R; Xiong X; Gajjar A
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):554-61. PubMed ID: 25160611
[TBL] [Abstract][Full Text] [Related]
17. Subtle white matter volume differences in children treated for medulloblastoma with conventional or reduced dose craniospinal irradiation.
Reddick WE; Russell JM; Glass JO; Xiong X; Mulhern RK; Langston JW; Merchant TE; Kun LE; Gajjar A
Magn Reson Imaging; 2000 Sep; 18(7):787-93. PubMed ID: 11027871
[TBL] [Abstract][Full Text] [Related]
18. Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group study.
Mulhern RK; Kepner JL; Thomas PR; Armstrong FD; Friedman HS; Kun LE
J Clin Oncol; 1998 May; 16(5):1723-8. PubMed ID: 9586884
[TBL] [Abstract][Full Text] [Related]
19. Medulloblastoma: clinical and biologic aspects.
Packer RJ; Cogen P; Vezina G; Rorke LB
Neuro Oncol; 1999 Jul; 1(3):232-50. PubMed ID: 11550316
[TBL] [Abstract][Full Text] [Related]
20. [Influence of surgery and radiotherapy on growth and pubertal development in children treated for brain tumour].
Birkholz D; Korpal-Szczyrska M; Kamińska H; Bień E; Połczyńska K; Stachowicz-Stencel T; Szołkiewicz A
Med Wieku Rozwoj; 2005; 9(3 Pt 2):463-9. PubMed ID: 16719158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
